Key Points Researchers have identified a connection between unfavorable gut bacteria and laboratory markers of inflammation in patients with non–small cell lung cancer, which in turn correlate with a poor response to immune checkpoint inhibitor therapy. Three phase 1...
Strictly necessary cookies
Strictly necessary cookies must always be activated so that we can save your cookie settings preferences.
If you deactivate this cookie, we will not be able to save your preferences. This means that every time you visit this website you will have to activate or deactivate cookies again.
Third party cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, or the most popular pages.
Leaving this cookie active allows us to improve our website.
Please activate the strictly necessary cookies first so that we can save your preferences!